Cardiology

Doç. Dr. Sinem Çakal

Doctor and researcher İstanbul Haseki Eğitim ve Araştırma Hastanesi İstanbul
Atrial FibrillationAortic Valve StenosisHeart Septal Defects, AtrialCoronary Artery DiseaseAneurysm, FalseMyocardial InfarctionThrombosisVentricular Dysfunction, Left
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Atrial Fibrillation 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Aortic Valve Stenosis 3 publications
  • Heart Septal Defects, Atrial 3 publications
  • Coronary Artery Disease 2 publications
  • Aneurysm, False 2 publications
  • Myocardial Infarction 2 publications
  • Thrombosis 2 publications
  • Ventricular Dysfunction, Left 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyCardiologysaglik.gov.trFrom source
  • Institutionİstanbul Haseki Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workAtrial FibrillationExtracted from 3 publications · Model version —From source
  • Publications50 publicationsEurope PMC, OpenAlexFrom source
  • ORCID0000-0003-2714-4584ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://hasekieah.saglik.gov.tr/TR-671576/doktorlar.html#sinem-cakalsaglik.gov.tr

Scientific work

Publications on Atrial Fibrillation

50 publications

  1. Incidence and Predictors of Clinical Outcomes in Real-Life Patients With Atrial Fibrillation Treated With Oral Factor Xa Inhibitors: The Follow-Up Results of the ANATOLIA-AF Study

    Clinical cardiology, 2025

    DOI 10.1002/clc.70088 PMID 39871620 Open-access full textSource: Europe PMC

  2. Review: Dietary Patterns in Atherosclerotic Cardiovascular Disease

    Bulletin of Cardiovasculer Academy, 2025

    DOI 10.4274/kvbulten.galenos.2025.24633 Open-access full textSource: OpenAlex

  3. Risk Stratification for Contrast-induced Nephropathy in NSTEMI: Does the H2FPEF Score Add Value?

    International Journal of the Cardiovascular Academy, 2025

    DOI 10.4274/ijca.2025.99609 Open-access full textSource: OpenAlex

  4. Real-World Data on Empagliflozin and Dapagliflozin Use in Patients with HEART Failure: The RED–HEART Study

    ESC Heart Failure, 2024

    DOI 10.1002/ehf2.15049 PMID 39340234 21 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. The impact of using SGLT-2 inhibitor on left ventricular longitudinal strain and NT-proBNP levels during six-month follow-up in diabetic patients with and without coronary artery disease with preserved ejection fraction

    Kardiologia Polska, 2024

    DOI 10.33963/v.phj.100613 PMID 38767161 10 citations (OpenAlex) Open-access full textSource: OpenAlex

  6. The Predictive Value of the Systemic Immune Inflammation Index for one-year Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Coronary Artery Disease

    Medical Bulletin of Haseki, 2023

    DOI 10.4274/haseki.galenos.2023.8895 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  7. CRT-101.01 Uric Acid to Albumin Ratio in Coronary Slow Flow

    JACC: Cardiovascular Interventions, 2023

    DOI 10.1016/j.jcin.2023.01.138 Open-access full textSource: OpenAlex

  8. The predictive value of the uric acid/albumin ratio in the phenomenon of coronary slow flow

    Annals of Medical Research, 2023

    DOI 10.5455/annalsmedres.2023.03.074 Open-access full textSource: OpenAlex

  9. Uric Acid to Albumin Ratio in Coronary Slow Flow

    Cardiovascular revascularization medicine, 2023

    DOI 10.1016/j.carrev.2023.05.122 Source: OpenAlex

  10. Hipertansiyon Tanı ve Tedavisine Güncel Yaklaşım

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.607 Open-access full textSource: OpenAlex

View all 50 publications